RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Tanmoy Mondal to Benzimidazoles

Back to Details
This is a "connection" page, showing publications Tanmoy Mondal has written about Benzimidazoles.
Tanmoy Mondal
Connection Strength
0.384
Benzimidazoles
  1. Kodishala RK, Sayyad K, Kowtharapu LP, Konduru N, Mondal T, Varkolu M, Gundekari S. Unspecified degradation impurities identification and characterization in bilastine and montelukast tablet formulations by using UPLC and LCMS/MS: Robustness by design expert and green assessment. Ann Pharm Fr. 2025 Nov; 83(6):1092-1113.
    View in: PubMed
    Score: 0.229
  2. Mondal T, Nautiyal A, Agrawal M, Mitra D, Goel A, Kumar Dey S. 18F-FDG-induced DNA damage, chromosomal aberrations, and toxicity in V79 lung fibroblast cells. Mutat Res Genet Toxicol Environ Mutagen. 2019 Nov; 847:503105.
    View in: PubMed
    Score: 0.156
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support